Objectives: This study was designed to demonstrate the prevalence of the newly discovered carbapenemhydrolysing class D enzymes, OXA-51-type and OXA-58, among clinical isolates of Acinetobacter spp.
Introduction
Acinetobacter spp. are predominant pathogens in ICUs in Turkey. 1 Antibiotic resistance rates to penicillins and cephalosporins among Acinetobacter spp. are high and therefore carbapenems are often the treatment of choice. However, resistance to this class of b-lactams is also increasing.
Resistance to carbapenems among Acinetobacter spp. is in many cases associated with reduced drug uptake due to porin deficiency and with reduced affinity to penicillin-binding proteins due to mutations. 2, 3 Recent data signify the responsibility of carbapenemases belonging to Ambler class B and Ambler class D among clinical isolates of Acinetobacter spp. [4] [5] [6] [7] [8] [9] In contrast to the relatively rare occurrence of class B metalloenzymes, the carbapenem-hydrolysing members of class D are widespread over multiple continents. A recent study conducted in Turkey with the contribution of seven centres revealed that 26.2% and 7.1% of ceftazidimeresistant clinical isolates of Acinetobacter spp. (n = 84) from seven ICUs are resistant to imipenem and meropenem, respectively. 13 This collection had been screened for (i) IMP and (ii) VIM-type metallo-b-lactamases and as well as for (iii) OXA-23, -27, -49, (iv) OXA-25, -26, -40 and (v) OXA-48-type carbapenem-hydrolysing oxacillinases with consensus primers, but failed to show the existence of such enzymes (F. Kolayli, G. Gacar and H. Vahaboglu, unpublished data).
The current study is designed to explore the prevalence of recently identified subgroups of class D carbapenemases: OXA-51-type and OXA-58, among the above-mentioned collection of Acinetobacter spp. strains.
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Materials and methods
Bacterial strains, identification and antibiotic resistance tests
Bacterial strains used were those Acinetobacter spp. recovered from the collection stored during a previous study. 13 The collection was composed of ceftazidime-resistant clinical strains isolated in ICUs from seven University hospitals between April and June in 2003. 13 Selected strains were re-identified by the API20NE system (bioMérieux, Marcy-l'É toile, France) and later screened for a band of 0.4 kb in a PCR using the primers 5 0 -GAAGGTAGCTTGCTAC-3 0 and 5 0 -ACTATCTCTAGGTATTAACTAAAGT-3 0 with an annealing temperature of 50 C (designed by T. De Baere). Existence of the 0.4 kb band (from the 16S rRNA gene) was reported to be specific for genomic species 2 (Acinetobacter baumannii), 3 and 13TU. 15 Identification of these strains at genomic level was further confirmed with amplified ribosomal DNA restriction analysis (ARDRA) as indicated elsewhere. 16 MICs were determined by an agar dilution technique using Mueller-Hinton agar (Oxoid, Basingstoke, UK) with an inoculum of 10 4 cfu per spot as recommended by the Clinical and Laboratory Standards Institute (formerly NCCLS). Endpoints were read after 18 h of incubation at 37 C. E. coli ATCC 25922 was used as the control strain.
Antimicrobial agents, their sources and ranges tested were amikacin (Eczacibasi; 0. 
DNA isolation, PCR screening and sequence analysis
DNAs for b-lactamase screening by PCR were extracted simply by incubating dense bacterial suspensions at 95 C for 10 min and sedimenting the debris for 10 min at 12 000 g.
PCR screenings were accomplished in a final volume of 50 mL with a 5 mL DNA extract. The master mixture was composed of 1· Buffer [supplied with DNA Taq polymerase (Fermentas, Lithuania)], 1.5 mM MgCl 2 , 0.8 mM dNTPs, 50 pmol primers each and 1.5 U of Taq polymerase. Amplification was accomplished after a 5 min denaturation at 95 C by 40 cycles of 1 min at 57 C, 1.5 min at 72 C and 1 min at 94 C. PCR products were run on a 1.5% agarose gel at constant 12 V/cm and visualized using a UV lamp.
For both bla OXA-58 and bla OXA-51-type two sets of primer pairs were used. One pair amplified the gene from the 5 0 and 3 0 ends and the other set from inner sequences. For OXA-58, 58A- 0 -GTGTTGGTTATGG-CAATGCAGATA-3 0 was used. Screenings were performed by outer-most primers, probes were generated by inner primers and sequencing was performed by both sets to obtain accurate sequence readings on both strands.
The sequence analyses were accomplished after product purification using High Pure PCR Product Purification Kit (Roche Diagnostics, Basel, Switzerland). The sequencing was performed with two sets of primers on both strands. The sequence analysis method used was dye terminator cycle sequencing with the ABI Prism BigDye Terminator kit (Applied Biosystems, Foster City, CA, USA). The assay was carried out according to a standard protocol. Data were collected on an ABI 377 automated fluorescence sequencer.
Sequence data were read and edited by two freeware programs: Chromas pro (http://www.technelysium.com.au) and BioEdit (version 7.0.5.2).
Enzyme extraction and IEF
Crude cell extracts were prepared by sonication. Analytical isoelectric focusing (IEF) was performed on 5% polyacrylamide gels containing ampholytes (pH range, 3-10; Fluka, Switzerland) with a Model 111 Mini IEF Cell (Bio-Rad Laboratories, USA). 17 Enzymes were focused at constant 1 W for 45 min and detected by overlaying the gel with 1 mM nitrocefin solution. Known enzymes, SHV-1 (pI 7.6), OXA-14 (pI 6.2) and TEM-1 (pI 5.4) were used as references. 18 Plasmid isolation, restriction enzyme digestion of genomic DNA, Southern hybridization and genotyping with PFGE Plasmids were isolated using the alkaline-lysis method, run on a 0.9% agarose gel at a constant 8 V/cm for 1 h, stained with ethidium bromide and visualized on a UV transilluminator. 17 For the Southern hybridization of genomic DNA restriction fragments the isolation method depended on guanidine thiocyanate lysis. This method is fully described in the literature. 19 Plasmids were digested with EcoRV (Fermentas) and the genomic DNAs were digested with PvuII (Fermentas) at 37 C. All were run on a 0.9% agarose gel at a constant 6 V/cm, visualized using a UV lamp and later the EcoRV-digested plasmids and PvuII-digested genomic DNAs were transferred to positively charged nylon membranes (Roche) using capillary blotting method.
Probes were generated by labelling PCR products internal to the bla OXA-58 and bla OXA-51-type by supplementing the master mixture with Dig-dUTP (Roche). Probes were purified with High Pure PCR Product Purification Kit (Roche) before hybridization. Southern hybridization and detection steps were accomplished using the Dig-dUTP detection kit as recommended by the manufacturer (Roche).
For pulsed-field gel electrophoresis (PFGE), SmaI-digested genomic DNA was prepared according to the instructions recommended by Bio-Rad (Hercules, CA, USA). Electrophoresis was performed in a 1% agarose gel [in 0.5· TBE (Tris-borate-EDTA) buffer] and fragments were separated for 20 h at 6 V/cm at 14 C by using a CHEF-DRII system (Bio-Rad), with initial and final pulse times of 5 and 30 s, respectively. DNA fingerprints were compared visually.
Results
A total of 70 Acinetobacter spp. from the 84 isolates stored during a previous study were recovered. 13 Two strains, isolated in 1999 in Kocaeli University Hospital's ICU, were included in the study as well. Altogether, 72 strains from six centres were studied. Since these strains had been identified previously, they were checked only by using classical methods such as oxidationfermentation reaction in TSI agar, oxidase production and colony appearance and later the collection was PCR screened for the existence of bla OXA-51-type and bla OXA-58 .
PCR screening and sequence data from bla oxa-51-type -positive isolates Among the studied 72 strains 56 (77.8%) were positive with primers specific to bla OXA-51-type .
PCR-positive strains were grouped according to imipenem and meropenem resistance phenotypes (resistant, MIC ‡ 8 mg/L (n = 32), sequence data were obtained from nine isolates among which bla OXA-66 (n = 6) was the most prevalent variant. Two strains (AO14, AO28), both from the same centre, contained a novel variant of OXA-51 which was assigned OXA-86 (accession # DQ149247). This new variant was confirmed with two independent amplifications from the strains AO14 and AO28. The distribution of OXA-51 variants among contributing centres is shown in Table 1 .
Multiple amino acid alignment of bla OXA-51-type revealed that OXA-86 differs by four amino acids from the other members such as Thr replaced Ala at positions 12 and 31, Ile replaced Thr at position 74 and Ile replaced Val at position 101 (according to DBL numbering). 20 PCR screening with primers specific to bla PCR screening with the bla OXA-58 -specific primer set of the 72 isolates and later the sequence data from PCR products (95% of the gene) revealed the existence of this gene among 10 strains, which were also positive for bla OXA-51-type .
OXA-58 producers were from multiple centres.
Identification and MICs for bla OXA-58 -positive isolates
All of these 10 isolates were re-identified as A. baumannii by API20NE. This was further confirmed by the existence of 0.4 kb genomic species 2, 3 and 13TU (A. baumannii), specific PCR fragment in all strains. ARDRA patterns of the digested products were identical to each other and consistent with DNA group 2 according to a previously reported data. 17 The MICs and the distribution of these strains between centres are shown in Table 2 . All of these strains, except AO66 (OXA-58 plus OXA-68 producer), were pandrug-resistant.
Plasmid and Southern hybridization studies of bla OXA-58 -positive isolates
Plasmid isolation from these strains revealed the existence of multiple plasmids (data not shown). Restriction patterns of plasmids with EcoRV were polymorphic, such that five patterns were observed (Figure 1a) . 
OXA-51-type b-lactamases
Southern hybridization of EcoRV-digested plasmids was positive with an OXA-58-specific probe and revealed that the genes were located on (approx.) 11 and 12 kbp fragments (Figure 1b) . On the other hand, Southern hybridization with an OXA-51-typespecific probe of plasmids was negative (data not shown) whereas the genomic DNAs were positive (Figure 2 ). This indicated the plasmidic spread of OXA-58 among those strains bearing bla OXA-51-type genes on their chromosomes.
IEF and macro-restriction analysis of bla oxa-58 -positive isolates IEF patterns of crude enzyme extracts were identical (data not shown). All isolates were hyperproducers for pI > 8.5 enzymes, which were consistent with those chromosomal enzymes of Acinetobacter spp., and additionally all displayed two almost identical activities at pI points 6.2 and 7.2. The enzymatic activity located to pI approx. 7.2 is consistent with OXA-58.
14 However, we observed this band in OXA-58-negative strains as well.
IEF, at least in our conditions, was not discriminative between OXA-51 variants. Although in silico analysis with deduced protein sequences suggested highly different pI values for various OXA-51 variants, the enzymes in crude extracts failed to migrate readily and to separate from each other on the gel. This imperfect migration of enzymes in acrylamide-polyacrylamide gels might be due to the electrophoresis conditions in our laboratory or due to the multimeric forms of these enzymes. 21 Macro-restriction analysis, with at least three different patterns, revealed a multiclonal spread of bla OXA-58 gene (Figure 3 ). 
Discussion
This study demonstrated that (i) OXA-51-type enzyme-producing Acinetobacter spp. is highly prevalent and scattered around different parts of the country; (ii) among the clonally variable strains bearing chromosomally located bla OXA-51-type genes, the plasmidic bla OXA-58 gene is readily disseminating and (iii) isolates with OXA-51-type plus OXA-58 enzymes are often associated with pandrug resistance. OXA-51 was first detected in Argentina among genetically distinct clinical isolates of A. baumannii, 11 whereas OXA-58 was detected among some isolates in Toulouse (France) in 2003. 6, 14 However, more recent studies revealed that both genes exist in carbapenem-resistant clinical isolates of Acinetobacter spp. from various continents and for even more than 10 years in some countries. 8, 10 In this study we could not detect bla OXA-51-type genes in all strains as was the case in one other study. 10 It is not clear, therefore, whether these resistance genes are acquired or occur naturally in Acinetobacter spp. 12 In one recent study, bla OXA-51-type genes were suggested to be chromosome borne, as was suggested among those bla OXA-58 -positive isolates in this study.
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Some of the OXA carbapenemases other than OXA-51 variants were shown to be plasmid borne and mostly associated with insertion sequences but not integrons. 14, 22, 23 However, from one strain-not mentioned in this study-we were able to transfer another OXA-51 variant (OXA-87, GenBank accession # DQ348075) to E. coli DH5a (currently, more data are not available), indicating that bla OXA-51 variants might jump to plasmids as well.
On the other hand, bla OXA-58 was originally found to be plasmidic and shown to be located on a 11 kbp EcoRV fragment. 6 In this study the bla OXA-58 gene was found to be located on different-sized (11 and 12 kbp) fragments.
Since IEF was not discriminative between the alleles of OXA-51-type enzymes we selected representative strains for sequence analysis according to imipenem-meropenem resistance phenotypes. Interestingly, OXA-66 was the most prevalent type among IMP S -MEM S phenotype. This is in contrast with previous data, where MICs of IMP for several OXA-66 producers were above the breakpoint. 21 However, beyond b-lactamases, especially for those OXA-type enzymes, some porin-efflux barriers play a decisive role in the resistance phenotypes of Acinetobacter.
OXA-51-type plus OXA-58 double enzyme producers were found to be pandrug-resistant. This finding is consistent with the previous data. 10 Of note was that the MICs of tigecycline, a new antibiotic on the market, were above the acceptable level (susceptible, MIC £ 2 mg/L; FDA, 2005) and therefore disappointing. 24, 25 Data from the plasmid patterns (data not shown), Southern hybridization and PFGE revealed that bla OXA-58 gene has been disseminated among multiple clones of Acinetobacter on different gene fragments. This indicated a high dissemination potential. High antibiotic consumption in ICUs will probably continue to provide enough pressure to maintain these highly contagious resistance genes as a growing problem.
This study further indicated that OXA-carbapenemases, especially those multiple-OXA carbapenemase producers, deserve attention as a significant health problem. OXA-51-type b-lactamases
